Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Icahn School of Medicine at Mount Sinai
University of Tennessee Graduate School of Medicine
Boston Medical Center
University of Athens
University College, London
Boston Medical Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
University of Tennessee
National Cancer Institute (NCI)
Asan Medical Center
Nantes University Hospital
Fred Hutchinson Cancer Center